DK0714912T3 - Funktionelt aktive selektin-deriverede peptider og ligander for GMP-140 - Google Patents

Funktionelt aktive selektin-deriverede peptider og ligander for GMP-140

Info

Publication number: DK0714912T3
Authority: DK; Denmark
Prior art keywords: gmp; alpha; sialyated; ligands; peptides
Prior art date: 1990-07-17

Application number

DK95202380T

Other languages

English (en)

Inventor

Rodger P Mcever

Original Assignee

Univ Oklahoma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-17

Filing date

1991-07-17

Publication date

2003-02-03

1991-07-17 Application filed by Univ Oklahoma filed Critical Univ Oklahoma

2003-02-03 Application granted granted Critical

2003-02-03 Publication of DK0714912T3 publication Critical patent/DK0714912T3/da

Links

108010035766 P-Selectin Proteins 0.000 title abstract 4
102000008212 P-Selectin Human genes 0.000 title abstract 4
108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000184 Selectins Proteins 0.000 title abstract 2
102000003800 Selectins Human genes 0.000 title abstract 2
239000003446 ligand Substances 0.000 title 1
AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 title 1
150000001720 carbohydrates Chemical group 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
PNIWLNAGKUGXDO-LNCRCTFVSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 PNIWLNAGKUGXDO-LNCRCTFVSA-N 0.000 abstract 1
102100021333 Alpha-(1,3)-fucosyltransferase 7 Human genes 0.000 abstract 1
108010024212 E-Selectin Proteins 0.000 abstract 1
102000015689 E-Selectin Human genes 0.000 abstract 1
101000819503 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 Proteins 0.000 abstract 1
101001022183 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 Proteins 0.000 abstract 1
101001022175 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 Proteins 0.000 abstract 1
101000862183 Homo sapiens Alpha-(1,3)-fucosyltransferase 10 Proteins 0.000 abstract 1
101000862213 Homo sapiens Alpha-(1,3)-fucosyltransferase 11 Proteins 0.000 abstract 1
101000819497 Homo sapiens Alpha-(1,3)-fucosyltransferase 7 Proteins 0.000 abstract 1
108010092694 L-Selectin Proteins 0.000 abstract 1
108090001090 Lectins Proteins 0.000 abstract 1
102000004856 Lectins Human genes 0.000 abstract 1
102000010836 Lymphocyte Homing Receptors Human genes 0.000 abstract 1
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 abstract 1
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
239000000370 acceptor Substances 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 abstract 1
238000003776 cleavage reaction Methods 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
239000002523 lectin Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000014508 negative regulation of coagulation Effects 0.000 abstract 1
230000007017 scission Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C07K14/70564—Selectins, e.g. CD62
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Cell Biology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK95202380T 1990-07-17 1991-07-17 Funktionelt aktive selektin-deriverede peptider og ligander for GMP-140 DK0714912T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55419990A	1990-07-17	1990-07-17
US65048491A	1991-02-05	1991-02-05

Publications (1)

Publication Number	Publication Date
DK0714912T3 true DK0714912T3 (da)	2003-02-03

Family

ID=27070521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95202380T DK0714912T3 (da)	1990-07-17	1991-07-17	Funktionelt aktive selektin-deriverede peptider og ligander for GMP-140

Country Status (9)

Country	Link
EP (2)	EP0714912B1 (da)
JP (5)	JP3096305B2 (da)
AT (1)	ATE224911T1 (da)
AU (2)	AU660627B2 (da)
CA (1)	CA2086323C (da)
DE (1)	DE69133120T2 (da)
DK (1)	DK0714912T3 (da)
ES (1)	ES2183851T3 (da)
WO (1)	WO1992001718A2 (da)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5800815A (en) *	1903-05-05	1998-09-01	Cytel Corporation	Antibodies to P-selectin and their uses
US5464778A (en) *	1989-03-08	1995-11-07	Board Of Regents Of The University Of Oklahoma	Glycoprotein ligand for P-selectin and methods of use thereof
JPH05504470A (ja) *	1989-10-20	1993-07-15	ニューイングランド・メディカル・センター・ホスピタルズ・インコーポレーテッド	Ｐａｄｇｅｍを介した細胞結合の阻害
US6387884B1 (en)	1990-06-18	2002-05-14	Stanford University	Leukocyte homing modulation
US6391857B1 (en)	1990-06-18	2002-05-21	Stanford University	Methods and compositions for endothelial binding
NZ240316A (en) *	1990-10-25	1996-12-20	Univ Michigan	Compound for treating disease mediated by the elaboration of elam-1 on endothelial cells
US6309639B1 (en)	1991-02-05	2001-10-30	The Board Of Regents Of The University Of Oklahoma	Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US6124267A (en) *	1991-02-05	2000-09-26	Southpac Trust Internationals, Inc.	O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US5807745A (en) *	1991-03-11	1998-09-15	New England Medical Center Hospitals, Inc.	Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component
DE69233654D1 (de) *	1991-04-19	2006-10-19	Univ Leland Stanford Junior	Zusammensetzungen und methoden für die verknüpfung von endothelzellen
US6121233A (en)	1991-04-19	2000-09-19	John L. Magnani	Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
JPH06507639A (ja) *	1991-05-03	1994-09-01	ザロックフェラーユニバーシティ	セレクチンとｂ百日咳毒素の間のアミノ酸シーケンスの相同性−それから誘導されるペプチド、それに対する抗体、薬剤組成物
EP0584244A1 (en) *	1991-05-14	1994-03-02	The Board Of Regents Of The University Of Oklahoma	Peptide inhibitors of inflammation
US5646123A (en) *	1991-06-10	1997-07-08	Alberta Research Council	Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
JPH07507040A (ja) *	1991-09-10	1995-08-03	セントコー，インコーポレイテッド	セレクチンによって介在される炎症のペプチド阻害剤
WO1993005803A1 (en) *	1991-09-25	1993-04-01	Genetics Institute, Inc.	Anti-inflammatory selectin inhibitors
CA2104099A1 (en) *	1991-12-18	1993-06-19	George A. Heavner	Peptide inhibitors of inflammation mediated by selectins
EP0639224B1 (en) *	1992-04-30	2000-06-28	Genentech, Inc.	Lectin domain variants of selectin
US6033667A (en) *	1992-05-05	2000-03-07	Cytel Corporation	Method for detecting the presence of P-selectin
ATE237353T1 (de) *	1992-05-05	2003-05-15	Aeres Biomedical Ltd	Antikörper gegen p-selectin und ihre verwendung
US5643873A (en) *	1992-05-06	1997-07-01	Affymax Technologies N.V.	Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US5648458A (en) *	1992-05-06	1997-07-15	Affymax Technologies N.V.	Peptides and compounds that bind to ELAM-1
US5728802A (en) *	1992-05-06	1998-03-17	Affymax Technologies N.V.	Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
JPH08504171A (ja) *	1992-05-28	1996-05-07	セントコー・インコーポレーテッド	セレクチン結合のペプチド阻害剤
EP0656904A1 (en) *	1992-05-28	1995-06-14	Centocor Inc.	Peptide inhibitors of selectin binding
US5440015A (en) *	1992-07-21	1995-08-08	Glycomed Incorporated	Selectin peptide medicaments for treating disease
CA2144180A1 (en) *	1992-09-08	1994-03-17	George A. Heavner	Peptide inhibitors of cellular adhesion
DE69331331T2 (de)	1992-10-02	2002-08-14	Alberta Research Council, Edmonton	Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide
US5843707A (en) *	1992-10-23	1998-12-01	Genetics Institute, Inc.	Nucleic acid encoding a novel P-selectin ligand protein
US6277975B1 (en)	1992-10-23	2001-08-21	Genetics Institute, Inc.	Fusions of P-selectin ligand protein and polynucleotides encoding same
AU677261B2 (en) *	1992-10-23	1997-04-17	Genetics Institute, Llc	Novel P-selectin ligand protein
EP0668907A1 (en) *	1992-11-16	1995-08-30	Board Of Regents Of The University Of Oklahoma	Glycoprotein ligand for p-selectin and methods of use thereof
WO1994014836A1 (en) *	1992-12-18	1994-07-07	Centocor, Inc.	Peptide inhibitors of selectin binding
US5856300A (en) *	1994-05-12	1999-01-05	T Cell Sciences, Inc.	Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
DK0730608T3 (da)	1993-05-17	2002-07-22	Avant Immunotherapeutics Inc	Præparater omfattende komplementrelaterede proteiner og carbohydrater og fremgangsmåder til fremstilling og anvendelse af præparaterne
US5976540A (en) *	1993-05-17	1999-11-02	T Cell Sciences, Inc.	Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
US5750508A (en) *	1993-06-16	1998-05-12	Glycomed Incorporated	Sialic acid/fucose based medicaments
WO1995014787A1 (en) *	1993-11-22	1995-06-01	Centocor, Inc.	Peptide inhibitors of selecting binding
CA2142153A1 (en) *	1994-03-04	1995-09-05	Jacques Banville	Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5663151A (en) *	1994-03-04	1997-09-02	Bristol-Myers Squibb Company	Sulfated α-glycolipid derivatives as cell adhesion inhibitors
WO1995030001A2 (en) *	1994-04-28	1995-11-09	Genetics Institute, Inc.	Novel p-selectin ligand protein
US5686426A (en) *	1994-11-17	1997-11-11	Bristol-Myers Squibb Company	Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
JPH11508131A (ja) *	1995-06-14	1999-07-21	ザジェネラルホスピタルコーポレーション	Ｐ−セレクチンリガンドおよび関連分子並びに方法
US5747463A (en) *	1995-11-13	1998-05-05	Bristol-Myers Squibb Company	Malonate derivatives of glycolipids as cell adhesion inhibitors
US6709656B1 (en)	1996-06-10	2004-03-23	Thomas Boren	Helicobacter pylori adhesin binding group antigen
ATE348163T1 (de)	1998-10-23	2007-01-15	Amgen Inc	Thrombopoietin substitute
US7488590B2 (en)	1998-10-23	2009-02-10	Amgen Inc.	Modified peptides as therapeutic agents
US6660843B1 (en)	1998-10-23	2003-12-09	Amgen Inc.	Modified peptides as therapeutic agents
JP5183010B2 (ja)	2002-05-16	2013-04-17	グリコミメティクス，インコーポレイテッド	セレクチンによって媒介される機能を阻害するための化合物および方法
DE602004011272T2 (de)	2003-11-19	2008-12-24	Glycomimetics, Inc.	Spezifischer antagonist sowohl für e- als auch p-selektine
EP1773400A2 (en)	2004-07-08	2007-04-18	Amgen Inc.	Therapeutic peptides
CA2580796C (en)	2004-09-24	2013-03-26	Amgen Inc.	Modified fc molecules having peptides inserted in internal loop regions
WO2007021721A2 (en)	2005-08-09	2007-02-22	Glycomimetics, Inc.	Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
US8008453B2 (en)	2005-08-12	2011-08-30	Amgen Inc.	Modified Fc molecules
SI2264043T1 (en)	2005-09-02	2018-01-31	Glycomimetics, Inc.	HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS
US8895510B2 (en)	2008-04-08	2014-11-25	Glycomimetics, Inc.	Pan-selectin inhibitor with enhanced pharmacokinetic activity
US8921328B2 (en)	2010-09-14	2014-12-30	Glycomimetics, Inc.	E-selectin antagonists
EP2794626B3 (en)	2011-12-22	2020-08-05	GlycoMimetics, Inc.	E-selectin antagonist compounds
HUE038423T2 (hu)	2012-12-07	2018-10-29	Glycomimetics Inc	E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
CN107108679B (zh)	2014-12-03	2020-10-23	糖模拟物有限公司	E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂
WO2017127422A1 (en)	2016-01-22	2017-07-27	Glycomimetics, Inc.	Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en)	2016-03-02	2022-04-05	Glycomimetics, Inc	Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en)	2016-08-08	2022-09-06	Glycomimetics, Inc.	Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
BR112019006642A2 (pt)	2016-10-07	2019-07-02	Glycomimetics Inc	antagonistas multiméricos de e-selectina altamente potentes
KR20250159733A (ko)	2017-01-11	2025-11-11	브리스톨-마이어스 스큅 컴퍼니	Psgl-1 길항제 및 그의 용도
PE20250933A1 (es)	2017-03-14	2025-04-02	Five Prime Therapeutics Inc	Anticuerpos de union a vista a ph acido
CA3054605A1 (en)	2017-03-15	2018-09-20	Glycomimetics, Inc.	Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
EP3717013A1 (en)	2017-11-30	2020-10-07	GlycoMimetics, Inc.	Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
US11548908B2 (en)	2017-12-29	2023-01-10	Glycomimetics, Inc.	Heterobifunctional inhibitors of E-selectin and galectin-3
AU2019230013A1 (en)	2018-03-05	2020-09-10	Glycomimetics, Inc.	Methods for treating acute myeloid leukemia and related conditions
SG11202008593PA (en)	2018-03-21	2020-10-29	Five Prime Therapeutics Inc	ANTIBODIES BINDING TO VISTA AT ACIDIC pH
AU2019301120A1 (en)	2018-07-11	2021-02-25	Bristol-Myers Squibb Company	Antibodies binding to VISTA at acidic pH
US11845771B2 (en)	2018-12-27	2023-12-19	Glycomimetics, Inc.	Heterobifunctional inhibitors of E-selectin and galectin-3
AU2021314104A1 (en) *	2020-07-20	2023-01-19	Insmed, Inc.	Methods for extracting neutrophil serine proteases and treating dipeptidyl peptidase 1-mediated conditions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3625214A (en)	1970-05-18	1971-12-07	Alza Corp	Drug-delivery device
US4244946A (en)	1979-06-11	1981-01-13	The Salk Institute For Biological Studies	Water-soluble peptides affecting gonadal function
US4305872A (en)	1979-10-19	1981-12-15	Kenneth Wingrove	Polypeptide derivatives
US4316891A (en)	1980-06-14	1982-02-23	The Salk Institute For Biological Studies	Extended N-terminal somatostatin
US4792525A (en)	1982-08-04	1988-12-20	La Jolla Cancer Research Foundation	Tetrapeptide
US4906474A (en)	1983-03-22	1990-03-06	Massachusetts Institute Of Technology	Bioerodible polyanhydrides for controlled drug delivery
US4629784A (en)	1983-08-16	1986-12-16	The University Of Georgia Research Foundation, Inc.	Synthesis of cyclopropane amino acids
US4752569A (en) *	1984-06-21	1988-06-21	The Regents Of The University Of California	Sialylated Lewisx epitope, antibodies and diagnosis
US4783330A (en) *	1984-11-15	1988-11-08	New England Medical Center Hospitals, Inc.	Monoclonal antibodies to activated platelets
US4789734A (en)	1985-08-06	1988-12-06	La Jolla Cancer Research Foundation	Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
US4904596A (en) *	1985-08-07	1990-02-27	Fred Hutchinson Cancer Research Center	Hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside
US4925673A (en)	1986-08-18	1990-05-15	Clinical Technologies Associates, Inc.	Delivery systems for pharmacological agents encapsulated with proteinoids
US5030723A (en) *	1988-05-31	1991-07-09	The Biomembrane Institute	Long-chain glycolipid structure
JPH05504470A (ja) *	1989-10-20	1993-07-15	ニューイングランド・メディカル・センター・ホスピタルズ・インコーポレーテッド	Ｐａｄｇｅｍを介した細胞結合の阻害

1991
- 1991-07-17 DK DK95202380T patent/DK0714912T3/da active
- 1991-07-17 DE DE69133120T patent/DE69133120T2/de not_active Expired - Fee Related
- 1991-07-17 EP EP95202380A patent/EP0714912B1/en not_active Expired - Lifetime
- 1991-07-17 JP JP03517240A patent/JP3096305B2/ja not_active Expired - Fee Related
- 1991-07-17 CA CA002086323A patent/CA2086323C/en not_active Expired - Fee Related
- 1991-07-17 WO PCT/US1991/005059 patent/WO1992001718A2/en not_active Ceased
- 1991-07-17 EP EP19910916882 patent/EP0544815A1/en not_active Withdrawn
- 1991-07-17 AU AU86207/91A patent/AU660627B2/en not_active Ceased
- 1991-07-17 ES ES95202380T patent/ES2183851T3/es not_active Expired - Lifetime
- 1991-07-17 AT AT95202380T patent/ATE224911T1/de not_active IP Right Cessation
1995
- 1995-04-28 AU AU17731/95A patent/AU697488B2/en not_active Ceased
1998
- 1998-08-03 JP JP10219500A patent/JPH11147900A/ja not_active Withdrawn
2000
- 2000-11-22 JP JP2000356784A patent/JP2001197899A/ja not_active Withdrawn
2003
- 2003-06-23 JP JP2003178744A patent/JP2004002444A/ja not_active Withdrawn
2005
- 2005-05-26 JP JP2005154747A patent/JP2005255691A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
DE69133120D1 (de)	2002-10-31
JP2005255691A (ja)	2005-09-22
AU1773195A (en)	1995-07-06
EP0714912B1 (en)	2002-09-25
JP2004002444A (ja)	2004-01-08
ATE224911T1 (de)	2002-10-15
EP0544815A1 (en)	1993-06-09
EP0714912A2 (en)	1996-06-05
WO1992001718A2 (en)	1992-02-06
EP0714912A3 (en)	1996-06-26
CA2086323C (en)	2002-05-14
JPH05509330A (ja)	1993-12-22
CA2086323A1 (en)	1992-01-18
JPH11147900A (ja)	1999-06-02
AU660627B2 (en)	1995-07-06
JP3096305B2 (ja)	2000-10-10
AU8620791A (en)	1992-02-18
JP2001197899A (ja)	2001-07-24
WO1992001718A3 (en)	1992-05-14
AU697488B2 (en)	1998-10-08
ES2183851T3 (es)	2003-04-01
DE69133120T2 (de)	2003-05-15

Publication	Publication Date	Title
DE69133120D1 (de)	2002-10-31	GMP-140 Ligand
Spiro et al.	1974	Structure of the O-glycosidically linked carbohydrate units of fetuin
Gabius	1997	Animal lectins
Cantoni et al.	1998	p49, a putative HLA class I‐specific inhibitory NK receptor belonging to the immunoglobulin superfamily
Tanaka et al.	1964	Serine and threonine glycosidic linkages in bovine submaxillary mucin
Stamenkovic et al.	1991	The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2–6 sialyltransferase, CD75, on B cells
Labeta et al.	1993	Release from a human monocyte‐like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14
Kobata	1993	Glycobiology: an expanding research area in carbohydrate chemistry
ATE319091T1 (de)	2006-03-15	Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ES2090132T3 (es)	1996-10-16	Variantes de interleuquina-3(il-3) con cisteina añadida y sus modificaciones quimicas.
Matsumoto et al.	1982	Structural study of the sugar chains of human lactoferrin: finding of four novel complex-type asparagine-linked sugar chains
Blithe	1993	Biological functions of oligosaccharides on glycoproteins
US4444757A (en)	1984-04-24	Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
Childs et al.	1981	Differences in carbohydrate moieties of high molecular weight glycoproteins of human lymphocytes of T and B origins revealed by monoclonal autoantibodies with anti-I and anti-i specificities
TSUJI et al.	1986	Structures of the carbohydrate chains of membrane glycoproteins IIb and IIIa of human platelets
Cahan et al.	1980	Polyorna virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes
Dahms et al.	1985	Lymphocyte function-associated antigen 1 (LFA-1) contains sulfated N-linked oligosaccharides.
NO971621L (no)	1997-06-12	Keratinocyttvekstfaktoranaloger
Samor et al.	1982	Preliminary results on the carbohydrate moiety of factor VIII/von Willebrand factor (FVIII/vWf)
Hirabayashi	1993	A general comparison of two major families of animal lectins
Efremov et al.	1965	Differences in cattle globins
EP1245575A3 (en)	2002-11-20	Functionally active selectin-derived peptides and ligand for GMP140
Bell et al.	1977	Effect of galactose oxidase, with and without prior sialidase treatment, on the viability of erythrocytes in circulation.
WO2002022784A2 (en)	2002-03-21	Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g
Zenteno et al.	2000	Identification of lectin isoforms in juvenile freshwater prawns Macrobrachium rosenbergii (DeMan, 1879)